Others (1) Publications in which a researcher has participated View referenced research data.

in the year 2017 Remove filter
filter_list Type (aggr.) Others from 2017 to 2017

2017

  1. Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin [Oncotarget, 6, (2015), (18875-18890)]. doi: 10.18632/oncotarget.4303

    Oncotarget